
MARÍA
HERNÁNDEZ SÁNCHEZ
Researcher in the period 2013-2017
Publications (20) MARÍA HERNÁNDEZ SÁNCHEZ publications
2023
-
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions
Cancer Genetics, Vol. 272-273, pp. 16-22
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
2022
-
TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914
2021
-
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Blood Cancer Journal, Vol. 11, Núm. 7
-
The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment
Diagnostics, Vol. 11, Núm. 5
2020
-
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792
-
Integrated genomic analysis of chromosomal alterations and mutations in B-cell acute lymphoblastic leukemia reveals distinct genetic profiles at relapse
Diagnostics, Vol. 10, Núm. 7
2019
-
1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia
Clinical and Experimental Medicine, Vol. 19, Núm. 2, pp. 261-267
-
DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains
Experimental Hematology, Vol. 72, pp. 9-13
2018
-
Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 3, pp. 633-642
-
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
BioMed Research International, Vol. 2018
2017
-
Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes
Cancer Letters, Vol. 409, pp. 42-48
-
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
Journal of Hematology and Oncology, Vol. 10, Núm. 1
-
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
Oncotarget, Vol. 8, Núm. 33, pp. 54297-54303
-
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040
2016
-
MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion
Leukemia Research, Vol. 46, pp. 30-36
2015
2014
-
Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia
BioMed Research International, Vol. 2014
-
TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations
BioMed Research International, Vol. 2014